HY-6725
N/A
Report date: 2026/03/06 20:02:51
NME
Base Information
Drug NameHY-6725
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNewsoara Biopharma Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesNewsoara Biopharma Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A